Home Caprotec Bioanalytics

Caprotec Bioanalytics

In operation
Series B
A Biotechnology Company

Basic Information

Caprotec Bioanalytics has developed a groundbreaking proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner. Caprotec's Capture Compound Mass Spectrometry (CCMS) technology is based on multifunctional small molecules (capture compounds) used for targeting, capturing, and isolating proteins according to their function. For many applications, CCMS significantly outperforms shotgun methods—thus addressing an unmet need within the proteomics community.
Caprotec Bioanalytics
Berlin,Berlin,Germany
15~50 people
January 01, 2006
info@caprotec.com